Neutroprotective efficacy of sodium tanshinone B on hippocampus neuron in A rat model of focal cerebral ischemia

Chinese Journal of Integrative Medicine

Volumn 18, Issue 11, 2012, Pages 837-845

  Cai, Qing ^a   Wang, Hong Wu ^a   Hua, Sheng Yu ^a   Tan, Jun Zhen ^a   Zhou, Tao ^a   Li, Chun Shen ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Ca+2; Hippocampus; Ischemia reperfusion injury; N methyl D aspartic acid receptor; Sodium tanshinone

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; EXCITATORY AMINO ACID; GLUTAMIC ACID; INHIBITORY AMINO ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; SODIUM TANSHINONE B; TANSHINONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN WATER CONTENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; FOCAL CEREBRAL ISCHEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVOUS SYSTEM PARAMETERS; NEUROPROTECTION; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REPERFUSION INJURY; SHAM PROCEDURE; WESTERN BLOTTING;

ANIMALS; BRAIN ISCHEMIA; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DITERPENES, ABIETANE; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; HIPPOCAMPUS; MODELS, BIOLOGICAL; NEURONS; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 84872107086     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-012-1266-9     Document Type: Article

References (32)

1. Ban JY, Cho SO, Choi SH, Ju HS, Kim JY, Rae K, et al. Neuroprotective effect of Smitacis chinae rhizome on NMDA-induced neurotoxicity in vitro and focal cerebral ischemia in vivo. J Pharmacol Sci 2008;106:68-77.
2. Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 2004;61:657-668. (Pubitemid 38446410)
3. Gassen M, Lamensdorf I, Armony T, Finberg JP, Youdim MB. Attenuation of methamphetamine induced dopaminergic neurotoxicity by flupirtine: microdialysis study on dopamine release and free radical generation. J Neurol Transm 2003;110:171-182. (Pubitemid 36216499)
4. Hou ST, MacManus JP. Molecular mechanisms of cerebral ischemiainduced neuronal death. lnt Rev Cytol 2002;221 93-148. (Pubitemid 35429861)
5. 2+ exchanger in excitotoxicity. Cell 2005;120:275-285. (Pubitemid 40174769)
6. 2+ signals and neuronal death in brain ischemia. Stroke 2007;38 (Suppl 2):674-676. (Pubitemid 46184239)
7. Lo EH. Moskowitz MA, Jacobs TP. Exciting, radical, suicidal: how brain cells die after stroke. Stroke 2005;36:189-192. (Pubitemid 40170779)
8. Sarraf-Yazdi S, Sheng H, Miura Y, McFarlane C, Dexter F, Pearistein R, et al. Relative neuroprotective effects of dizocilpine and isoflurane during focal cerebral ischemia in the rat. Anesth Analg 1998;87:72-78. (Pubitemid 28311614)
9. Kemp JA, McKernan AM. NMDA receptor pathways as drug targets. Nat Neurosci 2002; 5(suppl):1039-1042. (Pubitemid 35247194)
10. Birmingham K. Future of neuroprotective drugs in doubt. Nat Med 2002:8:5. (Pubitemid 34101702)
11. lkonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 2002;1:383-386. (Pubitemid 37159164)
12. Huang YE, Liu ML, Dong MO, Yang WC, Zhang B, Luan LL, et al. Effects of sodium tanshinone II A suiphonate on hypoxic pulmonary hypertension in rats in vivo and on Kv2.1 expression in pulmonary artery smooth muscle cells in vitro. J Ethnopharmacol 2009;125:436-443.
13. Liu J, Morton J, Miedzyblocki M, Lee TF, Bigam DL, Fok TF, et al. Sodium tanshinone II A sulfonate increased intestinal hemodynamics without systemic circulatory changes in healthy newborn piglets. Am J Physiol Heart Circ Physiol 2009;297:H1217-H1224.
14. Liu SX, Li YM, Fang WR. Protective effect of sodium tanshinone B on focal cerebral ischemia-reperfusion injury in rats. J China Pharmaceut Univ (Chin) 2008;39:338-342.
15. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91. (Pubitemid 19040218)
16. Kawamura S, Yasui N, Shirasawa M, Fukasawa H. Rat middle cerebral artery occlusion using an intraluminal thread technique. Acta Neurochir 1991;109:126-132.
17. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986;17:1304-1308. (Pubitemid 17008976)
18. Swanson RA, Morton MT. Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990;10:290-293. (Pubitemid 20096202)
19. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007;87:179-197. (Pubitemid 46860315)
20. Ploughman M, Windle V. MacLellan CL, White N, Doré JJ, Corbett D. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke 2009;40:1490-1495.
21. Dromerick AW, Edwards DF, Hahn M. Does the application of constraint-induced movement therapy during acute rehabilitation reduce arm impairment after ischemic stroke? Stroke 2000;31 2984-2988.
22. Siironen J, Juvela S, Kanarek K, Vilkki J, Hernesniemi J, Lappalainen J. The met allele of the BDNF Val66met polymorphism predicts poor outcome among survivors of aneurysmal subarachnoid hemorrhage. Stroke 2007;38:2858-2860. (Pubitemid 47494031)
23. Myers WA, Churchill JD, Muja N, Garraghty PE. Role of NMDA receptors in adult primate cortical somatosensory plasticity. J Comp Neurol 2000;418:373-382. (Pubitemid 30127682)
24. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 1999;81:163-221. (Pubitemid 29094735)
25. Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000:403:316-321. (Pubitemid 30062388)
26. Chen M, Lu TJ, Chen XJ, Zhou Y, Chen Q, Feng XY, et al. Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance. Stroke 2008:39:3042-3048.
27. Kunkle DD, Hendrickson AE, Wu JY, Schwartzkroin PA. Glutamic acid decarboxylase (GAD) immunocytochemistry of developing rabbit hippocampus. J Neurosci 1986;6:541-552. (Pubitemid 16125049)
28. Somogyi P, Hodgson AJ, Smith AD, Nunzi MG, Gorio A, Wu JV. Glutamate decarboxylase immunoreactivity in the hippocampus of the cat: distribution of immunoreactive synaptic terminals with special reference to the axon initial segment of pyramidal neurons. J Neurosci 1983;3:1450-1468. (Pubitemid 13016171)
29. Kirino H. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982;239:57-69.
30. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990;13:171-182. (Pubitemid 20100647)
31. Peruche B, Krieglstein J. Mechanisms of drug actions against neuronal damage caused by ischemia: an overview. Prog Neuropsychopharmacol Biol Psychiat 1993;17:21-70.
32. Takahashi K, Ouyang X, Komatsu K, Nakamura N, Hattori M, Baba A, et al. Sodium tanshinone II A sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells. Biochem Pharmacol 2002;64:745-749.